Company: Bristol-Myers Squibb
Liaison(s): Erik Rubin
Bristol-Myers Squibb ( BMS ) is a global biopharmaceutical company with a mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases, such as cancer, cardiovascular disease, fibrosis and immunological diseases. The role of the BMS R&D Pharmaceutical Development division ( PD ) is to design, scale up, and develop safe and cost-effective manufacturing processes for drug substance and drug product to support drug discovery, safety, and clinical development studies, global registrations, and product commercialization. PD manages the portfolio of projects in development and desires a framework to facilitate trade-off and resourcing decisions. The goal of this project is to create a dynamic and visual tiered model that can serve as a prioritization tool. To accomplish this objective, the team performed primary and secondary research through interviews with various PD leaders to determine the best framework for the model. These interviews also examined the characteristics by which projects are separated and a scoring method to quantify relevant criteria. Completion of this project will provide PD with a tiered scoring system with weighted tiers as an organizational framework for the placement of projects. In addition to designing the prioritization model, the team performed an empirical test with hypothetical assets to assess the usability of the framework.